Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Utility of dopaminergic stabilizers in neuropsychiatric disorders confirmed with (-)-OSU-6162

April 20, 2001

Mitochondrial function activators under development at Takeda

April 19, 2001

First patient dosed in pivotal trial of Onyx LES for aneurysms

April 19, 2001

Delta opioid receptor agonists and their use reported by Pfizer

April 18, 2001

New Neurogen compounds bind to the GABA-A receptor benzodiazepine site

April 18, 2001

Paxil approved for generalized anxiety disorder

April 18, 2001

Advisory committee review of Xyrem rescheduled

April 18, 2001

Pivotal trial of Neotrofin for Alzheimer's disease begins enrolling patients

April 18, 2001

MediChem and Signal use structural proteomics technologies to develop novel CNS drugs

April 18, 2001

Micro Therapeutics cleared to commence separate pivotal trial of Onyx LES for AVMs

April 17, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 1, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
CINP 2026: Gut microbiota could predict antidepressant response
BioWorld
The gut microbiota may be altered in people with depression as a result of treatment. These microorganisms reorganize differently in individuals who respond to...
Ascending BCI systems deepen national security, ethical concerns
BioWorld
Ready or not, the future has arrived. Novel AI and brain-computer interface (BCI) systems are no longer confined to the realm of science fiction. As an...
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...